Literature DB >> 6336912

Polycystic kidney disease: a predominance of giant nephrons.

J J Grantham.   

Abstract

Polycystic kidney disease is a bilateral disorder that affects approximately 200,000-400,000 persons in the United States. The most common form of the disease is inherited as an autosomal dominant trait (ADPKD). It typically causes renal insufficiency by the fifth or sixth decade of life. The disease is characterized by the progressive enlargement of a portion of renal tubule segments (proximal, distal, loop of Henle, collecting duct). The tubules enlarge from a normal diameter of 40 microns to several centimeters in diameter, causing marked gross and microscopic anatomic distortion. The cause of the cystic change in the tubules is unknown, but current possibilities include obstruction of tubule fluid flow by hyperplastic tubule cells, increased compliance of the tubule basement membranes, and/or increased radial growth of cells in specific portions of the renal tubule. Several studies show that the epithelia of the cysts continue to transport Na+, K+, Cl-, H+, and organic cations and anions in a qualitative fashion similar to that of the tubule segment from which they were derived. ADPKD, then, is a disease in which some gigantic renal tubules, over a period of several decades, impair the function of nonaffected nephrons and thereby lead to renal failure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336912     DOI: 10.1152/ajprenal.1983.244.1.F3

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

Review 1.  Rationale for early treatment of polycystic kidney disease.

Authors:  Jared J Grantham
Journal:  Pediatr Nephrol       Date:  2014-07-15       Impact factor: 3.714

Review 2.  Comparative pathology of canine hereditary nephropathies: an interpretive review.

Authors:  C A Picut; R M Lewis
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

Review 3.  Kidney: polycystic kidney disease.

Authors:  Binu M Paul; Gregory B Vanden Heuvel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-03       Impact factor: 5.814

4.  Differential rescue of the renal and hepatic disease in an autosomal recessive polycystic kidney disease mouse mutant. A new model to study the liver lesion.

Authors:  B K Yoder; W G Richards; C Sommardahl; W E Sweeney; E J Michaud; J E Wilkinson; E D Avner; R P Woychik
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

5.  Evidence for proximal tubular cell origin of a sarcomatoid variant of human renal cell carcinoma.

Authors:  D A Terreros; A Behbehani; F E Cuppage
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

6.  Refractory ascites associated with polycystic liver disease. Treatment with peritoneovenous shunt.

Authors:  T J McGarrity; K L Koch; D A Rasbach
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

7.  Decreased de novo synthesis of proteoglycans in drug-induced renal cystic disease.

Authors:  B Lelongt; F A Carone; Y S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

8.  Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2.

Authors:  T Arnould; L Sellin; T Benzing; L Tsiokas; H T Cohen; E Kim; G Walz
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

9.  In vitro function of cyst epithelium from human polycystic kidney.

Authors:  R D Perrone
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease.

Authors:  B D Cowley; F L Smardo; J J Grantham; J P Calvet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.